Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Benigno C. Valdez, Bin Yuan, David Murray, Yago Nieto, Uday Popat & Borje S. Andersson. (2022) Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells. Leukemia & Lymphoma 63:7, pages 1634-1644.
Read now
Read now
Eran Tallis & Gautam Borthakur. (2019) Novel treatments for relapsed/refractory acute myeloid leukemia with FLT3 mutations. Expert Review of Hematology 12:8, pages 621-640.
Read now
Read now
Laurence Booth, Jane L. Roberts, Francesca Avogadri-Connors, Richard E. Cutler$suffix/text()$suffix/text(), Alshad S. Lalani, Andrew Poklepovic & Paul Dent. (2018) The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells. Cancer Biology & Therapy 19:3, pages 239-247.
Read now
Read now
Articles from other publishers (12)
Nazmul Islam, Jamie S. Reuben, Justin Dale, Jon Gutman, Christine M. McMahon, Maria Amaya, Bruce Goodman, Joseph Toninato, Maura Gasparetto, Brett Stevens, Shanshan Pei, Austin Gillen, Sarah Staggs, Krysta Engel, Sarah Davis, Madelyne Hull, Elizabeth Burke, Lenny Larchick, Richard Zane, Grant Weller, Craig Jordan & Clay Smith. (2022) Machine Learning–Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine. JCO Clinical Cancer Informatics:6.
Crossref
Crossref
Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, Raquel Alcaraz, María José Herrero, Pau Montesinos, Francisco Abad-Santos & Miriam Saiz-Rodríguez. (2022) Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics 14:3, pages 559.
Crossref
Crossref
Si-Min Qi, Jinyun Dong, Zhi-Yuan Xu, Xiang-Dong Cheng, Wei-Dong Zhang & Jiang-Jiang Qin. (2021) PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy. Frontiers in Pharmacology 12.
Crossref
Crossref
Luigia Luciano, Mario Annunziata, Immacolata Attolico, Francesco Di Raimondo, Alessandro Maggi, Alessandra Malato, Bruno Martino, Fausto Palmieri, Fabrizio Pane, Nicola Sgherza & Giorgina Specchia. (2020) The multi‐tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real‐world data. European Journal of Haematology 105:1, pages 3-15.
Crossref
Crossref
Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha Mary Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath & Elisabeth A. Lasater. (2020) Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models. Haematologica 106:4, pages 1034-1046.
Crossref
Crossref
Benigno C. Valdez, Yang Li, David Murray, Yan Liu, Yago Nieto, Qaiser Bashir, Muzaffar H. Qazilbash & Borje S. Andersson. (2020) Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells. Experimental Hematology 81, pages 32-41.
Crossref
Crossref
Lohith Gowda & Chitra Hosing. 2020. Oncologic Critical Care. Oncologic Critical Care
1147
1153
.
Natasha S. Anstee, Rebecca A. Bilardi, Ashley P. Ng, Zhen Xu, Mikara Robati, Cassandra J. Vandenberg & Suzanne Cory. (2018) Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Cell Death & Differentiation 26:7, pages 1316-1331.
Crossref
Crossref
Kanak Joshi, Lei Zhang, Peter Breslin S.J.Jiwang Zhang. 2019. Leukemia Stem Cells in Hematologic Malignancies. Leukemia Stem Cells in Hematologic Malignancies
95
128
.
Lohith Gowda & Chitra Hosing. 2019. Oncologic Critical Care. Oncologic Critical Care
1
7
.
Dilana Staudt, Heather Murray, Tabitha McLachlan, Frank Alvaro, Anoop Enjeti, Nicole Verrills & Matthew Dun. (2018) Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance. International Journal of Molecular Sciences 19:10, pages 3198.
Crossref
Crossref
Chetasi Talati & Kendra Sweet. (2018) Recently approved therapies in acute myeloid leukemia: A complex treatment landscape. Leukemia Research 73, pages 58-66.
Crossref
Crossref